Acute migraine attack. Migraine
Conditions
Interventions
Intervention 1: Group 1: 37 people are non randomized selected and use Sumatriptan nasal spray(10mg) in the first two migraine attacks and Sumatriptan oral tablet (50mg)in the next two attacks. Int
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with 2 to 8 migraine attacks per month History of more than one year with migraine(with aura or without aura)
Exclusion criteria
Exclusion criteria: Pregnancy History of high blood pressure History of myocardial infarction History of stroke Allergy to sumatriptan History of coronary artery disease History of congenital heart disease Cardiovascular disease Pulmonary disease Cardiac arrhythmias Angina Cerebrovascular disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Migraine headache condition. Timepoint: Before the intervention and a month later. Method of measurement: Visual Analogue Scale/Headache Impact Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effect. Timepoint: At the onset of a migraine attack up to two hours after taking the drug. Method of measurement: Side effects questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzar mollaei
Kermanshah University of Medical Sciences
Outcome results
None listed